Last verified: today
Gymnema Sylvestre
Also known as: gurmar, Gymnema sylvestre R. Br., gymnemic acid, meshashringi
Evidence under review. — Not yet rated
Traditional herb that blunts sweet taste and may modestly reduce sugar cravings and fasting blood glucose.
-
What it does
Gymnema Sylvestre is a traditional medicinal plant whose active compounds, called gymnemic acids, temporarily block sweet taste receptors on the tongue. In small clinical trials, using gymnema...
-
Evidence quality
Evidence base hasn't been formally rated yet. See research below.
-
Clinical dose
No established dose from provided studies
What the Science Says
Gymnema Sylvestre is a traditional medicinal plant whose active compounds, called gymnemic acids, temporarily block sweet taste receptors on the tongue. In small clinical trials, using gymnema mints reduced sugar-sweetened beverage intake by up to 42% and lowered sugar cravings by 28% in people who identify as having a sweet tooth. Separate studies suggest it may modestly improve fasting blood glucose in people with mildly elevated levels, and may have some benefit on insulin resistance markers in people with obesity.
What It Doesn't Do
Not a proven weight-loss supplement. Won't cure diabetes or replace medication. No strong evidence it burns fat or builds muscle. The blood sugar effects are modest and studied only in small groups. Neuroprotective and anti-cancer claims come entirely from lab and animal studies — not human trials. ACE-inhibitor effects for blood pressure are computer-modeled only, not tested in people.
Evidence-Based Benefits
Reduces sugar cravings and sweet-beverage intake in adults who identify as having a sweet tooth.
Weak EvidenceEffective at: Ad libitum gymnema mints (up to 6/day) over 14 days
Temporarily blunts sweet taste perception, reducing the pleasantness and desire for chocolate and sweet foods.
Weak EvidenceEffective at: 4 mg gymnemic acids per dose
May modestly improve fasting blood glucose in adults with mildly elevated levels.
Weak EvidenceEffective at: No established dose from provided studies
Absorption & Bioavailability
Unknown — no pharmacokinetic data provided in the available studies. Gymnemic acids are delivered via oral mints or capsules in trials, but absorption rates are not characterized.
Red Flags to Watch For
- At least one case report links gymnema to drug-induced hypersensitivity syndrome — a serious allergic skin reaction.
- GLP-1 mimetic activity identified in lab studies means it could theoretically interact with diabetes medications or GLP-1 receptor agonist drugs.
- PPARγ inhibitory effects found in screening studies — long-term metabolic consequences are unknown and may complicate diabetes management.
- Most mechanistic research (neuroprotection, anti-cancer, ACE inhibition) is pre-clinical only — do not interpret lab findings as human benefits.
- Found in 674 registered supplement products, meaning wide variation in dose, form, and gymnemic acid concentration with little standardization.
Research Sources
- PubMed
- NIH DSLD
This information is for educational purposes only and is not medical advice. Always consult a healthcare professional before starting any supplement regimen. Last updated: 2026-05-25